THP from Tetrastigma hemsleyanum induces ferroptosis in TNBC cells, enhancing sensitivity to DOX. It improves tumor microenvironment, immune function, and organ toxicity caused by DOX, presenting a potential treatment strategy for TNBC.
Researchers found that Tetrastigma hemsleyanum polysaccharide (THP) reduced lung injury and inflammation in acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) by targeting the IFN-γ-JAK2/STAT signaling pathway, showing therapeutic potential.
Researchers found that supplementing Tetrastigma hemsleyanum with low-density blue light increased root tuber yield and flavonoid content, improving antioxidant properties. Understanding this can lead to better cultivation practices and potential medicinal applications.
EFT extracts from Tetrastigma hemsleyanum show promise in fighting cancer. Study explores how they work against pancreatic cancer cells. Important for potential cancer therapies.
TL;DR: STHP-5, a polysaccharide from Tetrastigma hemsleyanum, stimulates macrophages and activates TLR4, potentially serving as a novel immunomodulator.
This study analyzed the response of plants to cold stress. They found that genes related to plant hormone signaling pathways and ABA and ethylene played a vital role in cold tolerance. The findings provide insights for improving cold tolerance in plants.
Tetrastigma hemsleyanum is a useful plant for treating severe infectious diseases, but we don't know how it works. Understanding its mechanism could lead to better treatments.
Tetrastigma hemsleyanum polysaccharide (THP) reduces inflammation, promotes intestinal barrier integrity, regulates gut microbiota, and activates SCFAs-GPR41/43 signaling pathway in inflammatory bowel disease.
T. hemsleyanum has a long history in China for preventing and treating FS. Understanding its mechanisms can provide insights for potential therapeutic approaches.
Tetrastigma Hemsleyanum Diels et Gilg (SYQ) is a traditional Chinese medicine used for anti-tumor treatment. Researchers have found that the polysaccharide component of SYQ has antioxidant and anti-inflammatory properties. However, its impact on antitumor activity and the underlying mechanism are not yet well understood. This research aims to uncover the potential benefits of SYQ-PA in fighting tumors, shedding light on its significance for future cancer treatments.